These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27414743)

  • 21. Genetic polymorphisms of pharmacogenomic VIP variants in the Lahu population from Yunnan Province.
    Dou X; Yang S; Zhang W; Meng W; Zhao W; Hao J; Hu X; Guo L; Jin T
    Gene; 2022 Nov; 844():146825. PubMed ID: 35995116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variation of pharmacogenomic VIP variants in the Chinese Li population: an updated research.
    Yang S; Dou X; Wang Z; Zhang W; Ding K; Meng W; Li H; Liu J; Liu Y; Jin T
    Mol Genet Genomics; 2022 Mar; 297(2):407-417. PubMed ID: 35146537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Analysis of Pharmacogenomic VIP Variants of ABCB1, VDR and TPMT Genes in an Ethnically Isolated Population from the North Caucasus Living in Jordan.
    Al-Eitan LN; Al-Maqableh HW; Mohammad NN; Hakooz NM; Dajani RB
    Curr Drug Metab; 2020; 21(4):307-317. PubMed ID: 32368972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Genetic Variants in Cancer-Related Genes between Chinese Hui and Han Populations.
    Tian C; Chen Z; Ma X; Yang M; Wang Z; Dong Y; Yang T; Yang W
    PLoS One; 2015; 10(12):e0145170. PubMed ID: 26683024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Forensic characteristic and population structure dissection of Shaanxi Han population in the light of diallelic deletion/insertion polymorphism data.
    Liu Y; Jin X; Lan Q; Zhao C; Xu H; Xie T; Lan J; Tai Y; Zhu B
    Genomics; 2020 Nov; 112(6):3837-3845. PubMed ID: 32574833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Forensic features and genetic structure revealed by 47 individual identification InDels in the Shaanxi Han population.
    Xu H; Zhao C; Lan Q; Li S; Liu Y; Mei S; Fang Y; Zhu B
    Leg Med (Tokyo); 2022 May; 56():102030. PubMed ID: 35180607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of pharmacogenomic very important pharmacogenomic variants:
    Meng W; Zhang W; Yang S; Dou X; Liu Y; Li H; Liu J; Jin T; Li B
    Per Med; 2022 Sep; 19(5):403-410. PubMed ID: 35801384
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic polymorphisms of pharmacogenomic VIP variants in the Hui population from Ningxia Province of China.
    Zhou W; Guo J; Li Y; Ma X; Yang S; Wei J; Zhang H; Zhang S; Jin T
    Funct Integr Genomics; 2023 Mar; 23(2):85. PubMed ID: 36930384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphism of pharmacogenomic VIP variants in the Deng people from the Himalayas in Southeast Tibet.
    Shi X; Wang L; Du S; Wang H; Feng T; Jin T; Kang L
    Biomarkers; 2015 Jul; ():1-12. PubMed ID: 26227544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations.
    Ma X; Li Y; Zang X; Guo J; Zhou W; Han J; Liang J; Wan P; Yang H; Jin T
    Cancer Chemother Pharmacol; 2024 May; 93(5):481-496. PubMed ID: 38300251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethnic variability in the allelic distribution of pharmacogenes between Korean and other populations.
    Kim IW; Kim KI; Chang HJ; Yeon B; Bang SJ; Park T; Kwon JS; Kim S; Oh JM
    Pharmacogenet Genomics; 2012 Dec; 22(12):829-36. PubMed ID: 22955668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups.
    Li D; Zhang GL; Lou YQ; Li Q; Wang X; Bu XY
    J Clin Pharm Ther; 2007 Feb; 32(1):89-95. PubMed ID: 17286792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case study of the utility of the HapMap database for pharmacogenomic haplotype analysis in the Taiwanese population.
    Lin E; Hwang Y; Tzeng CM
    Mol Diagn Ther; 2006; 10(6):367-70. PubMed ID: 17154653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic polymorphisms in very important pharmacogenomic (VIP) variants in the Tibetan population.
    Jin TB; Xun XJ; Shi XG; Yuan DY; Feng T; Geng TT; Kang LL
    Genet Mol Res; 2015 Oct; 14(4):12497-504. PubMed ID: 26505400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of very important pharmacogene variants in the Tibetan population from China.
    Rong H; Dong H; He X; Yuan D; Bai M; Wang L; Liu T; He Y; Zheng J; Wang Y; Jin T
    Clin Exp Pharmacol Physiol; 2021 May; 48(5):668-678. PubMed ID: 32311112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variation of pharmacogenomic VIP variants in Zhuang nationality of southern China.
    Liu Y; Li H; Cao K; Liu J; Sun Y; Wu J; Xiong Z; Niu F; Li J; Jin T
    Pharmacogenomics J; 2021 Feb; 21(1):60-68. PubMed ID: 32699276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of CYP2C19, ABCB1 and PON1 polymorphisms in Chinese Han, Hui, Uygur and Kazak patients with coronary atherosclerotic heart disease.
    Ma L; Yuan Y; Li J; Yu C; Zhao J
    Int J Immunogenet; 2020 Dec; 47(6):539-545. PubMed ID: 32862511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional allele and genotype frequencies of CYP1A2, CYP2B6 and iNOS among mainland Chinese Tibetan, Mongolian, Uygur and Han populations.
    Qi GZ; Zhang ZY; Wang X; Yin SJ; Lou YQ; Zhang GL
    J Clin Pharm Ther; 2016 Feb; 41(1):84-91. PubMed ID: 26763760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic polymorphism analysis of CYP2C19 in Chinese Han populations from different geographic areas of mainland China.
    Chen L; Qin S; Xie J; Tang J; Yang L; Shen W; Zhao X; Du J; He G; Feng G; He L; Xing Q
    Pharmacogenomics; 2008 Jun; 9(6):691-702. PubMed ID: 18518848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Polymorphism analysis of 20 autosomal short-tandem repeat loci in southern Chinese Han population].
    Chen L; Lu HJ; DU WA; Qiu PM; Liu C
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 37(2):141-149. PubMed ID: 28219855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.